Investigating underlying risk as a source of heterogeneity in meta-analysis.

[1]  S Senn,et al.  Relation between treatment benefit and underlying risk in meta-analysis , 1996, BMJ.

[2]  S. Senn,et al.  IMPORTANCE OF TRENDS IN THE INTERPRETATION OF AN OVERALL ODDS RATIO IN THEMETA-ANALYSIS OF CLINICAL TRIALS. AUTHOR'S REPLY , 1994 .

[3]  Stephen Senn,et al.  Statistical Issues in Drug Development , 1997 .

[4]  R J Cook,et al.  A logistic model for trend in 2 x 2 x kappa tables with applications to meta-analyses. , 1997, Biometrics.

[5]  S G Thompson,et al.  A likelihood approach to meta-analysis with random effects. , 1996, Statistics in medicine.

[6]  H Kragt,et al.  Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. , 1992, Statistics in medicine.

[7]  H C Van Houwelingen,et al.  A bivariate approach to meta-analysis. , 1993, Statistics in medicine.

[8]  M. McIntosh,et al.  The population risk as an explanatory variable in research synthesis of clinical trials. , 1996, Statistics in medicine.

[9]  James K. Lindsey,et al.  Parametric Statistical Inference , 1996 .

[10]  S D Walter,et al.  Variation in baseline risk as an explanation of heterogeneity in meta-analysis. , 1997, Statistics in medicine.

[11]  J C Wakefield,et al.  Hierarchical models for multicentre binary response studies. , 1990, Statistics in medicine.

[12]  P. D. Oldham,et al.  A note on the analysis of repeated measurements of the same subjects. , 1962, Journal of chronic diseases.

[13]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[14]  F. Song,et al.  Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.